The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroids.

ABSTRACT:

Background and aims

Obesity has been reported to be one of the most frequent comorbidities in COVID-19 patients and associated with higher rates of in-hospital mortality compared to non-obese patients. Acute kidney injury (AKI) is also known to be a complication associated with obesity in critically-ill COVID-19 patients. We aimed to investigate whether obesity was associated with increased risk of in-hospital mortality and AKI among patients with COVID-19 treated with corticosteroids.

Methods

We utilized 9965 hospitalized COVID-19 patient data and divided patients who were treated with corticosteroids into 6 groups by body mass index (BMI) (less than 18.5, 18.5-25, 25-30, 30-35, 35-40, 40 kg/m² or greater). The association between BMI and in-hospital mortality an

SUBMITTER: So M 

PROVIDER: S-EPMC8714243 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature